Pet Overpopulation: Rich Doctor Puts His Money Where His Mouth Is
By Sharon L. Peter
s, Special for USA TODAY
A very rich, very impatient retired surgeon wants the pet overpopulation solved.
So Gary Michelson has put a hard-to-ignore enticement on the table: $75 million.
The person or group that comes up first with a safe, one-time non-surgical means to sterilize male and female cats and dogs gets $25 million, Michelson's non-profit Found Animals Foundation will announce today at the National Spay/Neuter Conference in Chicago. And up to $50 million more will be available to support the research of one or several individuals who come forward with plausible approaches.
"No one will stop what they're doing and turn their attention to this problem for $10 million. That's not enough," says Michelson, 59, a retired Los Angeles orthopedic surgeon who invented and patented hundreds of surgical instruments, won an infringement case in 2005 and landed at No. 317 on Forbes' 400 Richest Americans list last month.
Animal lover Michelson is convinced, like most animal-welfare experts, that if unwanted litters never materialized, U.S. shelters wouldn't be euthanizing 4 million to 6 million animals a year.
Experts and animal advocacy organizations from the Alliance for Contraception in Cats & Dogs, The American Association of Pet Product Manufacturers and other organizations have amassed information about U.S.
pet overpopulation, including:
Percentage of sexually intact pets:
Dogs: 27%
Cats: 14%
Percentage of unplanned litters:
Dogs: 50%
Cats: 75%
Pets sterilized after having puppy or kitten litters:
All: 80%
Delayed sterilization, often due to owners not realizing pregnancy can occur before age 1, results in millions of unwanted puppies and kittens every year.
He "absolutely" believes that the $25 million carrot, coupled with the cash grants to spur research, will prompt sufficient activity that an affordable non-surgical sterilant will be on the market within 10 years.
The solution may originate from any of several arenas — from human or animal researchers who are endocrinologists, neuroscientists, reproductive biologists, molecular technology experts, or even pharmacology specialists.
"We're completely agnostic regarding the approach," says foundation executive director Aimee Gilbreath. "We'll consider anything. We really believe if cutting-edge technologies are applied we can solve this.
"
The foundation is partnering with the Allia |